Loading...
Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications - reassuring insights from the United Kingdom PREPARE-IBD multi centre cohort study
Lamb, CA Sebastian, S Kent, Alexandra Segal, JP Gonzalez, HA Mehta, Shameer Subramanian, S Bhala, N Hicks, Lucy
Lamb, CA
Sebastian, S
Kent, Alexandra
Segal, JP
Gonzalez, HA
Mehta, Shameer
Subramanian, S
Bhala, N
Hicks, Lucy
Editors
Other contributors
Affiliation
Epub Date
Issue Date
2021-05-07
Submitted date
Alternative
Abstract
Citation
Lamb, C.A., Sebastian, S., Kent, A.J. et al. (2021) Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications - reassuring insights from the United Kingdom PREPARE-IBD multi centre cohort study. Alimentary Pharmacology and Therapeutics, 53(11), pp. 1236-1240. https://doi.org/10.1111/apt.16349
Publisher
Research Unit
PubMed ID
PubMed Central ID
Embedded videos
Additional Links
Type
Other
Language
en
Description
This is an accepted manuscript of an article published by Wiley in Alimentary Pharmacology and Therapeutics, available online at: https://doi.org/10.1111/apt.16349
The accepted version of the publication may differ from the final published version.
Series/Report no.
ISSN
0269-2813